Seal System Articles & Analysis
4 news found
Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive scarring of the lungs, which severely impairs lung function over time. Developing effective treatments for IPF has been a challenge for the medical community, as the mechanisms driving this disease are complex and not fully understood. To accelerate drug discovery, animal models that closely mimic the ...
November 7, 2018 — At VIVA 2018, the Vascular Interventional Advances annual conference held November 5–8 in Las Vegas, Nevada, Micah Watts, MD, presented findings from the first-in-human clinical trial of the Large Bore Closer vascular sealing system (Rex Medical). The trial evaluated 23 patients at a single site and assessed the safety and ...
The fibres also distribute and integrate extremely well as part of the conversion process and so no further edge sealing or pouching systems are required. “Wound care has been a focus area for SAF™ for a number of years and we are already actively working with customers and creating solutions for such applications. ...
Food and Drug Administration (FDA) has granted market clearance to Rex Medical’s bioresorbable Closer Vascular Sealing System (VSS) to achieve rapid hemostasis of femoral artery catheterizations. ...